{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"NeuroSense Therapeutics Ltd."},"Symbol":{"label":"Symbol","value":"NRSNW"},"Address":{"label":"Address","value":"11 HAMENOFIM STREET, BUILDING B, HERZLIYA, 4676670, Israel"},"Phone":{"label":"Phone","value":"+972 97996183"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Middle East"},"CompanyDescription":{"label":"Company Description","value":"NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its lead product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio."},"CompanyUrl":{"label":"Company Url","value":"https://www.neurosense-tx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alon Ben-Noon","title":"Chief Executive Officer & Director"},{"name":"Ferenc Tracik","title":"Chief Medical Officer"},{"name":"Hagit Binder","title":"Chief Operating Officer"},{"name":"Irit Shefer","title":"Head-Clinical Operations"},{"name":"Niva Russek Blum","title":"Chief Technology Officer"},{"name":"Oron Yacoby-Zeevi","title":"Chief Scientific Officer"},{"name":"Shiran Zimri","title":"Vice President-Research & Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}